Pasithea Therapeutics (KTTA) Total Non-Current Liabilities (2021 - 2024)
Historic Total Non-Current Liabilities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $163578.0.
- Pasithea Therapeutics' Total Non-Current Liabilities fell 3180.73% to $163578.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $163578.0, marking a year-over-year decrease of 3180.73%. This contributed to the annual value of $84366.0 for FY2023, which is 8950.94% down from last year.
- Pasithea Therapeutics' Total Non-Current Liabilities amounted to $163578.0 in Q3 2024, which was down 3180.73% from $93272.0 recorded in Q2 2024.
- Pasithea Therapeutics' Total Non-Current Liabilities' 5-year high stood at $1.5 million during Q4 2021, with a 5-year trough of $57650.0 in Q1 2024.
- For the 4-year period, Pasithea Therapeutics' Total Non-Current Liabilities averaged around $547590.1, with its median value being $528096.0 (2021).
- In the last 5 years, Pasithea Therapeutics' Total Non-Current Liabilities soared by 14721.0% in 2022 and then tumbled by 9268.06% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Total Non-Current Liabilities stood at $1.5 million in 2021, then tumbled by 44.64% to $804207.0 in 2022, then crashed by 89.51% to $84366.0 in 2023, then skyrocketed by 93.89% to $163578.0 in 2024.
- Its Total Non-Current Liabilities was $163578.0 in Q3 2024, compared to $93272.0 in Q2 2024 and $57650.0 in Q1 2024.